Cumberland Pharmaceutical CPIX Balance Sheet

Income Statement

Quarter End	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	96.7M	92.52M	90.78M	92.93M	89.47M	89.38M	87.75M	81.78M
Total Current Assets	45.34M	43.75M	49.16M	45.87M	43.81M	43.68M	41.77M	35.71M
Cash and Equivalents	17.27M	18.22M	19.54M	19.76M	16.39M	18.25M	18.51M	18.32M
Total Non-Current Assets	51.76M	48.77M	41.62M	47.34M	45.66M	45.7M	45.98M	46.43M
Total Liabilities	55.9M	53.31M	52.29M	56.95M	53.42M	52.54M	52.1M	52.52M
Total Current Liabilities	24.56M	24.25M	25.31M	28.58M	25.71M	26.96M	27.33M	27.98M
Total Non-Current Liabilities	51.35M	48.06M	44.68M	44.57M	43.78M	38.73M	37.69M	37.32M
Common Equity	48.05M	47.82M	47.53M	47.48M	47.38M	47.3M	47.19M	47.09M
Retained Earnings	-7.02M	-8.36M	-8.77M	-11.21M	-11.02M	-10.14M	-11.19M	-17.49M

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	93.41M	93.23M	112.69M	104.55M	96.46M	84.46M	92.93M	81.78M
Total Current Assets	65.55M	68.69M	59.12M	50.16M	49.97M	45.69M	45.87M	35.71M
Cash and Equivalents	34.51M	45.41M	27.94M	28.21M	24.75M	27.04M	19.76M	18.32M
Total Non-Current Assets	73.12M	63.92M	55.57M	51.09M	46.87M	42.6M	35.97M	29.26M
Total Liabilities	20.28M	29.31M	57.12M	53.46M	49.59M	41.86M	56.95M	52.52M
Total Current Liabilities	14.79M	17.69M	27.8M	24.15M	25.67M	19.28M	28.58M	27.98M
Total Non-Current Liabilities	9.59M	21.42M	49.32M	47.81M	38.92M	37.58M	44.57M	37.32M
Total Equity	73.12M	63.92M	55.57M	51.09M	46.87M	42.6M	35.97M	29.26M
Common Equity	54.64M	52.41M	51.1M	49.91M	49.12M	48.45M	47.48M	47.09M
Retained Earnings	18.61M	11.71M	4.75M	1.21M	-2.13M	-5.64M	-11.21M	-17.49M